Clinical Trials
1,067 trialsMorningLyte
The Lymphoma Academic Research Organisation
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Children's Hospital Medical Center, Cincinnati
Pirtobrutinib and Mosunetuzumab for the Treatment of Relapsed/Refractory Grades 1-3A Follicular Lymphoma, PROMOTE-FL Trial
University of Washington
Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders
City of Hope Medical Center
Mosunetuzumab Consolidation Therapy After autoSCT in r/r Aggressive B Cell Lymphoma
Washington University School of Medicine
FIL_GAZEBO
Fondazione Italiana Linfomi - ETS
Study on Treatment Mechanisms and Efficacy Prediction of Individualized Transcranial Magnetic Stimulation in Adults With Irritable Bowel Syndrome Using Multimodal MRI and High-Throughput Sequencing
The Affiliated Hospital of Hangzhou Normal University
Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies
Fred Hutchinson Cancer Center
Pomalidomide Plus Anti-CD20 Antibody and Prednisone in Frontline Indolent B-Cell Lymphoma
The First Affiliated Hospital of Soochow University
Pembrolizumab and Pralatrexate in Treating Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas
City of Hope Medical Center
huCART19-IL18-eDHFR Cells in Relapsed/Refractory Follicular Lymphoma
University of Pennsylvania
FERTILymph
University Hospital, Lille
Epcoritamab and Rituximab for First-line Follicular Lymphoma
Dana-Farber Cancer Institute
TAB
University of Cincinnati
HEMO-CONNECT
Centre Hospitalier de la côte Basque
PAPE-MID
Inonu University
Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases
Masonic Cancer Center, University of Minnesota
A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma
Memorial Sloan Kettering Cancer Center
0150-24 SOR
Soroka University Medical Center
CUREMZL002
Institute of Hematology & Blood Diseases Hospital, China
Administration of Repurposed Ketoconazole in Glioma Patients
Universitas Padjadjaran
PBID-12
Burdur Mehmet Akif Ersoy University
Mosunetuzumab With or Without Polatuzumab Vedotin and Obinutuzumab for the Treatment of Untreated Indolent B-Cell Non-Hodgkin Lymphoma
University of Washington
ZGR in TN FL
Institute of Hematology & Blood Diseases Hospital, China
RITALLO
University Hospital, Bordeaux
Nivolumab for Relapsed, Refractory, or Detectable Disease Post Chimeric Antigen Receptor T-cell Treatment in Patients With Hematologic Malignancies
University of Washington
CD70-targeted immunoPET Imaging of Malignant Cancers
RenJi Hospital
Loncastuximab Tesirine for the Treatment of Relapsed or Refractory B-Cell Malignancies
University of Washington
Family-Focused Study to Support Medication for Opioid Use Disorder
University of Wisconsin, Madison
SevAsthma
Assistance Publique - Hôpitaux de Paris
A Phase II Study of Axicabtagene Ciloleucel, an Anti-CD19 Chimeric Antigen Receptor (CAR) Tcell Therapy, in Combination With Radiotherapy (RT) in Relapsed/Refractory Follicular Lymphoma
M.D. Anderson Cancer Center
Genetically Engineered Lymphocyte Therapy After Peripheral Blood Stem Cell Transplant in Treating Patients With High-Risk, Intermediate-Grade, B-cell Non-Hodgkin Lymphoma
City of Hope Medical Center
REFRACT
University of Birmingham
Lenalidomide and Epcoritamab for the Treatment of Previously Untreated Follicular Lymphoma
City of Hope Medical Center
VR&depression
Sykehuset Innlandet HF
Carmustine, Etoposide, Cyclophosphamide, and Stem Cell Transplant in Treating Patients With HIV-Associated Lymphoma
City of Hope Medical Center
Dendritic Cell Therapy, Cryosurgery, and Pembrolizumab in Treating Patients With Non-Hodgkin Lymphoma
Mayo Clinic
Cannabis Use Disorder Treatment Study
The University of Tennessee, Knoxville
PAM-II
University Medical Center Groningen
CUB-HS2025
Jacobs University Bremen gGmbH
Echo Prompts
Ottawa Heart Institute Research Corporation
Clinical Trial of Lyophilized Powder for Inhalation of Recombinant Human Keratinocyte Growth Factor-2 (Rh-KGF-2) in The Treatment of Patients With Acute Respiratory Distress Syndrome
Shanghai Zhongshan Hospital
Brain Health Together: A Live-Streaming Group-Based Digital Program
University of California, San Francisco
Narrative Exposure Therapy for Adults With an Intellectual Disability
University of Nottingham
CUREFL03
Institute of Hematology & Blood Diseases Hospital, China
Decision Making Tool for Firearm Storage
University of Washington
Pevonedistat and Ibrutinib in Treating Participants With Relapsed or Refractory CLL or Non-Hodgkin Lymphoma
City of Hope Medical Center
PNOC020
University of Florida
FLOURISH
Sun Yat-sen University
AG-120 in People With IDH1 Mutant Chondrosarcoma
Memorial Sloan Kettering Cancer Center